The E6 and E7 genes of the cancer-associated human papillomavirus (HPV) types 16 (HPV16) and 18 (HPV18) can induce cell immortalization in vitro in normal human keratinocytes. This, however, is not associated with tumorigenicity in vivo. On the other hand, tumorigenicity of HPV18-positive HeLa cervical carcinoma cells can be suppressed by fusion of HeLa cells with normal human keratinocytes or fibroblasts. We have addressed the question of whether suppression of tumorigenicity in HeLa X fibroblast hybrid cells might be due to a reduced ability of these cells to express the HPV18 E6-E7 genes in vivo. Nontumorigenic hybrid cells and tumorigenic hybrid segregants were transplanted as organotypical cultures or injected subcutaneously into immunocompromised mice and were analyzed for HPV18 E6-E7 gene expression by RNA-RNA in situ hybridization. The tumorigenic hybrid cells showed a continuous and invasive growth that was associated with high levels of HPV18 E6-E7 mRNAs at all time points examined. In contrast, the nontumorigenic hybrid cells stopped cell proliferation approximately 3 days after transplantation. At this time they expressed the E6-E7 genes at low levels, whereas at day 2 high expression levels were observed. However, the mRNA levels of the cytoskeletal genes ,I-actin and vimentin remained high for at least 14 days, demonstrating that inhibition of growth and of HPV18 E6-E7 gene expression was not due to cell death. These results suggest that growth inhibition of the nontumorigenic HeLa x fibroblast hybrid cells in vivo might be caused by suppression of HPV18 E6-E7 gene expression and are compatible with the idea of an intracellular surveillance mechanism for HPV gene expression existing in nontumorigenic cells.
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Cancer of the uterine cervix is regarded as a late consequence of persistent infections of the cervical epithelium with human papillomaviruses (HPVs) (54, 62) . Of the more than 60 genotypes of HPVs identified so far, of which about one-third infect the anogenital tract of women and men (15, 42) , only certain HPV types, in particular HPV types 16 (HPV16) and 18 (HPV18), are strongly associated with malignant genital tumors. Altogether, about 90% of cervical carcinomas are positive for HPV DNA; HPV16 represents the most prevalent HPV type, followed by HPV18. Additional experimental data strongly indicate that, besides the presence of HPV DNA in cervical epithelium, other events are required for full malignant conversion of cells infected by "oncogenic" HPVs. A change in the state of the viral DNA may represent one factor in progression toward malignancy. In premalignant lesions of the cervix (cervical intraepithelial neoplasias) the viral DNA is present as a episome, with a tendency toward integration in higher-grade cervical intraepithelial neoplasias (29) . In cervical carcinomas either integrated or episomal HPV DNA or a mixture of both forms was detected (17, 31) , whereas cell lines established from cervical carcinomas have been shown to harbor exclusively integrated HPV16 or HPV18 DNA. The integrated viral DNA has usually suffered a disruption in the El and E2 open reading frames, accompanied in many cases by deletion of parts of the open reading frame E2-to-L2 region (1, 9, 18, 44, 55) . In all cell lines and the majority of carcinoma biopsies analyzed, the viral open reading frames E6 and E7 are preserved and expressed as mRNAs and proteins (43, 46, 48) . These data have indicated that expression of the HPV E6 and E7 genes may be crucial for maintenance of the transformed phenotype in vitro as well as of the malignant phenotype of cervical cancer cells and that DNA integration may represent a means for the E6-E7 genes to escape from regulation by viral control factors, such as the E2 trans repressor (5) .
Several studies have provided evidence that the HPV16 and HPV18 E6 and E7 genes can profoundly influence proliferation and differentiation capacities of rodent and human cells in tissue culture (in vitro). It has been shown for the HPV18-positive cervical carcinoma cell line C4-I that proliferation of these cells in vitro depends on a certain level of E6-E7 gene expression (53) . Transfection studies with rodent cells as targets have revealed that the E7 gene is able to induce immortalization of primary cells (3, 24) , malignant transformation of established cells (4, 23, 28) , and, in cooperation with an activated ras oncogene, malignant transformation of primary cells (12, 30, 35) . After transfection of the DNA of the cancer-associated HPV types, normal human epithelial cells gain an indefinite life span in vitro (i.e., cell immortalization) and show altered differentiation in vitro (16, 25, 32, 36, 41, 58) . Cell immortalization in vitro is brought about by the cooperative activities of the E6 and E7 genes (2, 21, 22, 33) .
A common feature of all HPV-immortalized keratinocyte lines tested so far is that they do not form tumors in nude mice. Thus, the ability to express the HPV16 or HPV18 E6-E7 genes in vitro, which results in cell immortalization, is obviously not sufficient to confer tumorigenic growth potential to these cells in vivo.
The lack of tumorigenicity of these HPV-immortalized cell lines may reflect some early stages in HPV-linked carcinogenesis in which HPV infection is only one of several necessary events. This is also evident from the long latency period between primary HPV infection and cancer appearance (which is of low incidence) and the detection of HPV16 infections also in women with normal cervical cytology (62) . In an attempt to explain these features at the cellular level, a model has been proposed that views the development of virus-linked human tumors as the result of a failing intracellular surveillance of persisting viral genes by putative cellular genes named cellular interfering factors (CIF genes) (60, 61) . In the case of HPV-associated genital tumors, the CIF genes are postulated to be present as intact genes only in nontumorigenic cells and to act in vivo by suppression of HPV E6-E7 gene expression (61) .
To examine the prediction that the HPV E6-E7 genes are negatively regulated in nontumorigenic cells in vivo, we used somatic cell hybrids that were established by fusion of tumorigenic HeLa cells with normal human fibroblasts (49, 51) . These hybrid cells show the phenomenon of tumor suppression when inoculated into nude mice, i.e., they are nontumorigenic in vivo, although they exhibit all characteristics of transformed cells in tissue culture (in vitro). Rare segregants have been isolated that express the tumorigenic phenotype, a property that has been correlated with the loss of one copy of fibroblast chromosome 11 (52) . We have used these hybrid cells, since HeLa cells are derived from an adenocarcinoma of the cervix and contain integrated and transcriptionally active HPV18 DNA (44) . The HeLa-specific HPV18 DNA integration pattern is retained in the hybrid cells, and E6-E7 transcription is observed in the nontumorigenic hybrid cells as well as in tumorigenic segregants grown in tissue culture (38, 45) . The nontumorigenic hybrid cells and their tumorigenic segregants are thus genetically closely related; they show the same transformed phenotype in vitro but differ drastically in their proliferation potential in vivo (nontumorigenic versus tumorigenic phenotype). We analyzed HPV18 E6-E7 gene expression by determination of mRNA levels in the nontumorigenic and tumorigenic hybrid cells in vivo after transplantation or subcutaneous inoculation into nude mice. In particular we wanted to examine whether the host-induced growth inhibition of the nontumorigenic hybrid cells is associated with a reduction in HPV18 E6-E7 mRNA levels. For this purpose we used RNA-RNA in situ hybridization on tissue sections, which allowed the determination of HPV18 mRNA levels in single cells in combination with a histological examination of the hybrid cell transplants. RNA analysis. Total RNA to be analyzed by Northern (RNA) blot hybridization was extracted from nodules grown for different lengths of time after subcutaneous injection. The RNA was prepared by the guanidinium isothiocyanate procedure (8) , separated by denaturing agarose gel electrophoresis, and transferred with capillary to Gene Screen Plus membranes. The probes used for the Northern blots were cDNA fragments specific for HPV18 E6-E7 or human a-actin and were labeled with 32P by random priming (20) .For in situ hybridization analyses, cRNA probes were used prepared by incorporation of either a-32p-or 35S-labeled CTP or UTP into transcripts synthesized in vitro from cDNAs cloned into the Bluescibe vector (Promega Biotec Co., Madison, Wis.). In addition to E6-E7 and human ,B-actin, a cRNA probe specific for the human vimentin gene, which was kindly provided by H. Herrmann (Division of Membrane Biology and Biochemistry), was used. As a negative control, cRNAs transcribed in the orientation yielding sequences identical to the mRNAs in question were used (sense cRNA instead of antisense cRNA).
MATERIALS AND METHODS

Somatic
In situ hybridization. A hybridization procedure based on the studies of Cox et al., (11) was carried out as described previously (7) , except that the proteinase K treatment of the sections was shortened to 10 to 15 min.
Indirect immunofluorescence. Both the histology and the patterns of HPV18 E6-E7 gene expression were consistent among the transplants harvested at the same time points. The data from these three experiments are described and discussed together.
Histological examination of the transplant sections revealed that the nontumorigenic cells initially continued to proliferate. Under the in vivo conditions employed here, this period lasted for about 3 days. Figure 3 shows the histology of sections of transplanted cells at low magnification; cells were harvested at day 2, 3, 6, and 14 p.t., respectively. At day 2 p.t., both tumorigenic and nontumorigenic cells had formed a thin epitheliumlike tissue ( Fig. 3a and b) . At day 3, the nontumorigenic cells were present in a yet larger number, but at no time point thereafter did they show further growth (Fig. 3b, d, f, and h) . The tumorigenic cells, on the other hand, continued to grow fast and invaded the mesenchyme of the host animal (Fig. 3a, c, e, and g ).
Dark-field photomicrographs showing the hybridization signals obtained from these sections after hybridization with 32P-labeled HPV18 E6*-E7 antisense RNA probe are presented in Fig. 4 . The tumorigenic cells showed a strong, homogeneous expression of the E6-E7 genes at all times analyzed (Fig. 4a, d , g, and j). At day 2, the mRNA level in the nontumorigenic cells was quite similar to that in the tumorigenic cells (Fig. 4b) . Already at day 3, however, the nontumorigenic cells showed a sharp reduction in the level of the E6-E7 mRNAs when compared with the tumorigenic cells harvested at the same time and in the nontumorigenic cells on day 2 p.t. (compare Fig. 4e with 4b and d) . These reduced levels persisted further ( Fig. 4h and k) (27) . Fig. 3 are shown. Note that at day 2 p.t. HPV18 E6-E7 gene expression in the nontumorigenic cells was very similar to that seen in the tumorigenic cells (a, b, c), but at day 3 (d, e, f) and later (day 6: g, h, i; day 14: j, k, 1) was drastically reduced. ,-Actin gene expression (c, f, i, 1), on the other hand, remained at high levels. Magnifications are as in Fig. 3 .
including the foci with increased E6-E7 mRNa levels in 14-day-old transplants (Fig. 5d , showing region corresponding to Fig. 5a and b) . This clearly excluded cross-contamination by tumorigenic cells.
The nontumorigenic cells showed heterogeneous behavior regarding the extent of E6-E7 mRNA suppression also at the earlier times p.t., as shown at higher magnification in Fig. 6 . Starting with day 3 p.t., in a large subset of the nontumorigenic cells HPV18 E6-E7 expression was completely shut off ( Fig. 6c and d) when compared with the hybridization signals obtained in the nontumorigenic cells at day 2 p.t. and also in the tumorigenic cells at day 3 and later. However, a further subset of the nontumorigenic cells showed a markedly reduced but still clearly detectable level of E6-E7 mRNAs (Fig. 6d) ; yet, none of these cells showed any reduction in P-actin or vimentin mRNA levels, confirming their viability until at least day 14 (Fig. 4c, f, i, and 1 ).
HPV18 E6-E7 gene expression after subcutaneous inoculation. HPV18 E6-E7 gene expression of the tumorigenic and nontumorigenic cells was also analyzed in nude mice after injection by the subcutaneous route (Fig. 7) . In this experiment tissue samples were removed from the sites of previous injection at days 5 and 21 (tumorigenic cells) or days 5 and 28 (nontumorigenic cells), respectively. The nontumorigenic cells were markedly down-regulated in their E6-E7 mRNA levels at both day 5 and 28 ( Fig. 7) . It has to be stressed, however, that even at day 28 there were some small regions still revealing hybridization levels above background, although always substantially lower than the corresponding signals seen over the tumorigenic cells. genic HeLa x fibroblast hybrid cells when comparing growth conditions in vitro (tissue culture) and in vivo (nude mice). We have chosen the hybrid cell lines 444 (nontumorigenic) and a tumorigenic segregant thereof (CGL3) as model system, since the extensive characterization of these two cell lines has shown their very close biochemical and genetic relationship (50) . For the tumorigenic HeLa x fibroblast segregant line, Northern blot and in situ hybridization experiments have established that the continuous and invasive growth in vivo of these cells was correlated with constantly high levels of HPV18 mRNAs at all times examined after transplantation or subcutaneous inoculation (Fig. 1, 4, 5, 6 , and 7).
The uncontrolled growth of the tumorigenic segregants impressively contrasted to the host-induced inhibition of cell growth of the nontumorigenic hybrids cells (Fig. 3 and 4) . Growth inhibition in vivo was apparently taking effect between day 3 and day 5 p.t., since from day 3 on the number of cell layers on the collagen gel did not increase further (compare Fig. 3d and f) . These data are in good agreement with the observations of Stanbridge and co-workers, who reported that proliferation was seen only for 3 to 4 days after subcutaneous inoculation of the nontumorigenic HeLa x fibroblast hybrid cells (50, 51) .
In vitro (i.e., either in petri dishes or as organotypical cultures on collagen) as well as in the initial period of growth in vivo (i.e., 2 days after transplantation of the organotypical cultures), the level of HPV18 E6-E7 mRNA in the nontumorigenic cells was as high as that in the tumorigenic hybrid cells (Fig. 1, 2, 3, and 4) . In all specimens taken at day 3 p.t., the HPV18 E6-E7 mRNA levels were already markedly reduced (Fig. 4) , and they were similarly reduced in all specimens taken at later times ( Fig. 3 and 4) . We noted, however, that the reduction of the HPV18 E6-E7 mRNA levels was not homogeneous in these cells. Whereas in the majority of cells HPV18 E6-E7 gene expression dropped below the level of detection of the in situ hybridization method, in a subset of cells expression was still obvious but Reduced levels of HPV18 E6-E7 mRNAs were also observed in the nontumorigenic cells after subcutaneous inoculation (Fig. 7) It is, however, completely unknown which cellular regulatory mechanisms are responsible (i) for down-regulation of the HPV18 E6-E7 genes and (ii) for growth inhibition of the nontumorigenic hybrid cells in vivo, and whether these are (partly or completely) different or identical. In the HeLa x fibroblast hybrids, the nontumorigenic phenotype is linked to the presence of two copies of fibroblast chromosome 11 (52) . In addition, a normal chromosome 11 is able to suppress tumorigenicity of HPV18-positive HeLa and HPV16-positive SiHa cervical carcinoma cells (26, 40) . Furthermore, it has been shown that human embryonic fibroblasts carrying a deletion in the short arm of one chromosome 11, in contrast to diploid human embryonic fibroblasts (47) , were susceptible to transformation by HPV16 early region DNA and efficiently expressed the viral genes. All of these data indicate that chromosome 11 probably harbors tumor suppressor genes whose loss of function might be important for the development of HPV-associated cervical carcinomas. Deletions in certain regions of chromosome 11 are also associated with Wilm's embryonic kidney tumor and with other malignancies and are implicated in the loss of tumor suppressor genes (56; for reviews, see references 37 and 39).
Experimental evidence for interactions between the products of cellular tumor suppressor genes and HPV transforming genes has recently been obtained by demonstrating complex formation between the retinoblastoma tumor suppressor gene product RB and the HPV16 and HPV18 E7 proteins (18, 34) , and between the cellular p53 protein and the HPV16 and HPV18 E6 proteins (57) . These data suggested that the HPV E7 and E6 proteins might interfere with the normal functions of the RB and p53 proteins, which seem to play crucial roles for normal cell growth control (10, 13) .
In the intracellular surveillance hypothesis, a class of cellular genes called CIF genes exists in normal cells; these genes can negatively regulate incoming viral oncogenes, such as the HPV18 and HPV16 E6-E7 genes. Furthermore, the irreversible inactivation or loss of these CIF genes is postulated to be necessary to release the HPV E6-E7 genes from cellular suppression in vivo and to represent an essential event in the multistep development of cervical carcinoma (60, 62) . In the context of this hypothesis, the shutdown of HPV18 E6-E7 gene expression in vivo in the nontumorigenic cells results from host-mediated activation of such cellular suppressor genes. With regard to the specific chromosome losses of tumorigenic hybrid segregants (52), intact CIF genes should be contributed by the normal parental cell to the nontumorigenic HeLa hybrid cells and be again lost in the tumorigenic segregants. This scenario would also provide a possible explanation for the nontumorigenic phenotype of HPV-immortalized human cells: cell immortalization in vitro due to expression of the HPV E6-E7 genes (2, 21-23) but nontumorigenicity in vivo at least in part due to suppression of the HPV E6-E7 genes. In vitro studies with 5-azacytidine have suggested the existence of host cell mechanisms that negatively regulate HPV E6-E7 transcription specifically in nontumorigenic HPV-containing cells but are not active under normal tissue culture conditions (38) . It remains to be clarified, however, whether the negative regulatory mechanisms induced in the nontumorigenic hybrid cells by
